Physician profile
Leslie Barry
NPI 1609178532
$4,220.60
in general payments reported to CMS, 2019-2025
25 companies · $868 in 2025
The $868 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $817 · 2022: $1,005 · 2023: $908 · 2024: $623 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,349 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,349.31 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,187.64 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $743.01 | 2021-2023 | Jardiance |
| Abiomed | $570.44 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $265.61 | 2021-2024 | Farxiga, Brilinta |
| Medtronic, INC. | $199.34 | 2022-2025 | Symplicity G3, Linq II, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.26 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $158.45 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $150.17 | 2021-2022 | |
| Abbott Laboratories | $125.85 | 2022-2025 | Jot Dx, Diamondback Coronary |
| Inspire Medical Systems, INC. | $101.74 | 2024-2025 | Inspire |
| Amgen INC. | $85.24 | 2021-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $69.80 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $67.27 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Regeneron Healthcare Solutions, INC. | $57.01 | 2023-2025 | Evkeeza |
| Pfizer INC. | $42.05 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $39.32 | 2022-2023 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $27.05 | 2025 | |
| Silk Road Medical, INC. | $26.71 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $25.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.49 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $20.37 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $16.86 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $16.14 | 2023 | Inpefa |
| Terumo Medical Corporation | $15.23 | 2022 | |
| Daiichi Sankyo INC. | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.